BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Examples of successful administration mechanisms for the delivery of Download Scientific Diagram Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype Peptide Therapy for Inflammation: A New Solution What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B